This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

FRANK W. NEWELL, M.D.; THOMAS C. BEAMAN, M.D.; LEON O. JACOBSON, M.D.; EDNA K. MARKS, B.S.; EVELYN O. CASTON, B.S.

AMA Arch Ophthalmol. 1957;57(6):846-848.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cysteine, administered parenterally to rats prior to total-body irradiation, has been reported by Patt and his co-workers¹ to increase the survival of the treated animals, whereas sodium chloride given before radiation or cysteine given afterwards does not. Von Sallmann² has described a deterrent effect of cysteine administered intravenously to rabbits before a single exposure to 1500 r delivered to the eye. Jacobson and his associates³ and Lorenz et al.⁴ have shown that hemopoietic cell suspensions or tissue transplants given subsequent to x-radiation have a significant effect upon the survival of rats, mice, and rabbits. There have been no reports that such postirradiation treatment might influence the development of cataracts.

It was observed that postirradiation treatment with mouse embryo cells appeared to have a deterrent effect upon the development of cataracts in a single group of mice that had been exposed to 750 r total-body x-radiation as . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Department of Surgery (Ophthalmology) and the Argonne Cancer Research Hospital, The University of Chicago.

Footnotes
Received for publication Nov. 5, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?